Skip to main content
. 2017 Oct 19;12:7721–7735. doi: 10.2147/IJN.S141052

Figure 2.

Figure 2

Osteogenic synergy of icariin and BMP2 measured by ALP activity quantitative assay. Rat BMSCs were treated in advance with 0.8 µg/mL BMP2 and different concentrations of icariin before 3 days and 7 days. *p<0.05 represents a significant difference to the group without the presence of icariin at the corresponding time point.

Abbreviations: ALP, alkaline phosphatase; BMSC, bone marrow mesenchymal stem cell.